China Pharma Holdings (CPHI) Return on Invested Capital (2011 - 2018)
China Pharma Holdings' (CPHI) quarterly Return on Invested Capital came in at 0.01% in Q4 2018, up 2.0% YoY from 0.01% in Q4 2017, and up 42.35% on a QoQ basis from 0.03% in Q3 2018.
China Pharma Holdings (CPHI) Return on Invested Capital (2011 - 2018) Analysis & Trends
China Pharma Holdings (CPHI) has 8 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2018.
- Quarterly Return on Invested Capital rose 2.0% year-over-year to 0.01% in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.01% (up 2.0% YoY) and the FY2025 annual result came in at 0.02%, up 1.0% from the prior year.
- Return on Invested Capital climbed to 0.01% in Q4 2018, from 0.03% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2016 to a low of 0.12% in Q4 2014.
- A 5-year average of 0.03% and a median of 0.01% in 2015 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2014 — Return on Invested Capital declined 9 bps — and 2015, when it grew 12 bps.
- Tracing CPHI's Return on Invested Capital over 5 years: stood at 0.12% in 2014, then jumped by 99 bps to 0.0% in 2015, then plunged by 587 bps to 0.01% in 2016, then plunged by 221 bps to 0.03% in 2017, then surged by 57 bps to 0.01% in 2018.
- The last three Return on Invested Capital figures came in at 0.01% (Q4 2018), 0.03% (Q3 2018), and 0.03% (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | -0.03% |
| Jun 30, 2018 | -0.03% |
| Mar 31, 2018 | -0.03% |
| Dec 31, 2017 | -0.03% |
| Sep 30, 2017 | -0.01% |
| Jun 30, 2017 | -0.01% |
| Mar 31, 2017 | -0.01% |
| Dec 31, 2016 | -0.01% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | -0.01% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.04% |
| Dec 31, 2014 | -0.12% |
| Sep 30, 2014 | -0.08% |
| Jun 30, 2014 | -0.06% |
| Mar 31, 2014 | -0.04% |